LLGL CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. LLGL Gen Silencer sind erhältlich als LLGL CRISPR/Cas9 Knockout Plasmide und LLGL Double Nickase Plasmide. LLGL CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
LLGL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
LLGL2 CRISPR/Cas9 KO Plasmid (h) | sc-404667 | h | Gene Knockout | GFP | 1 | ||
LLGL2 HDR Plasmid (h) | sc-404667-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
LLGL2 Double Nickase Plasmid (h) | sc-404667-NIC | h | Gene Knockout | Puromycin | 1 | ||
LLGL2 Double Nickase Plasmid (h2) | sc-404667-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
LLGL2 CRISPR/Cas9 KO Plasmid (m) | sc-432200 | m | Gene Knockout | GFP | 0 | ||
LLGL2 HDR Plasmid (m) | sc-432200-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
LLGL2 Double Nickase Plasmid (m) | sc-432200-NIC | m | Gene Knockout | Puromycin | 0 | ||
LLGL2 Double Nickase Plasmid (m2) | sc-432200-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
LLGL4 CRISPR/Cas9 KO Plasmid (h) | sc-411289 | h | Gene Knockout | GFP | 0 | ||
LLGL4 HDR Plasmid (h) | sc-411289-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
LLGL4 Double Nickase Plasmid (h) | sc-411289-NIC | h | Gene Knockout | Puromycin | 0 | ||
LLGL4 Double Nickase Plasmid (h2) | sc-411289-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
LLGL4 CRISPR/Cas9 KO Plasmid (m) | sc-431497 | m | Gene Knockout | GFP | 0 | ||
LLGL4 HDR Plasmid (m) | sc-431497-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
LLGL4 Double Nickase Plasmid (m) | sc-431497-NIC | m | Gene Knockout | Puromycin | 0 | ||
LLGL4 Double Nickase Plasmid (m2) | sc-431497-NIC-2 | m | Gene Knockout | Puromycin | 0 |
LLGL CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
LLGL2 CRISPR Activation Plasmid (h) | sc-404667-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
LLGL2 CRISPR Activation Plasmid (h2) | sc-404667-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
LLGL2 Lentiviral Activation Particles (h) | sc-404667-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
LLGL2 Lentiviral Activation Particles (h2) | sc-404667-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
LLGL2 CRISPR Activation Plasmid (m) | sc-432200-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL2 CRISPR Activation Plasmid (m2) | sc-432200-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL2 Lentiviral Activation Particles (m) | sc-432200-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL2 Lentiviral Activation Particles (m2) | sc-432200-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL4 CRISPR Activation Plasmid (h) | sc-411289-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL4 CRISPR Activation Plasmid (h2) | sc-411289-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL4 Lentiviral Activation Particles (h) | sc-411289-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL4 Lentiviral Activation Particles (h2) | sc-411289-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL4 CRISPR Activation Plasmid (m) | sc-431497-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL4 CRISPR Activation Plasmid (m2) | sc-431497-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL4 Lentiviral Activation Particles (m) | sc-431497-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LLGL4 Lentiviral Activation Particles (m2) | sc-431497-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |